Lubner David Charles
CIK 0001572000
Director
Filings
27
Latest Jun 3, 2026
Issuers covered
7
Showing
27 of 27
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +7.8% | +7.8% | +7.8% | +7.8% |
| 90 days | 1 | 0% | -59.3% | -59.3% | -59.3% | -59.3% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Lubner David Charles has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACLX | Arcellx, Inc. | 7 | Apr 28, 2026 |
| DYN | Dyne Therapeutics, Inc. | 5 | Apr 28, 2026 |
| CRGX | Cargo Therapeutics, Inc. | 4 | Aug 19, 2025 |
| VOR | Vor Biopharma Inc. | 4 | May 23, 2025 |
| PNT | Point Biopharma Global Inc. | 3 | Dec 27, 2023 |
| CBIO | Crescent Biopharma, Inc. | 2 | Jun 3, 2026 |
| IRON | Disc Medicine, Inc. | 2 | Mar 9, 2022 |
All filings
27 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|